GO:0000398 | mRNA splicing, via spliceosome | 7.48e-05 | 7.30e-01 | 4.083 | 4 | 15 | 128 |
GO:0008380 | RNA splicing | 2.00e-04 | 1.00e+00 | 3.717 | 4 | 21 | 165 |
GO:0010467 | gene expression | 2.77e-04 | 1.00e+00 | 2.605 | 6 | 49 | 535 |
GO:0005654 | nucleoplasm | 6.00e-04 | 1.00e+00 | 2.116 | 7 | 68 | 876 |
GO:0006370 | 7-methylguanosine mRNA capping | 8.65e-04 | 1.00e+00 | 5.499 | 2 | 5 | 24 |
GO:0015785 | UDP-galactose transport | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0004832 | valine-tRNA ligase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0032859 | activation of Ral GTPase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0050434 | positive regulation of viral transcription | 1.84e-03 | 1.00e+00 | 4.954 | 2 | 5 | 35 |
GO:0008175 | tRNA methyltransferase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0005459 | UDP-galactose transmembrane transporter activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0072334 | UDP-galactose transmembrane transport | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 1 |
GO:0030334 | regulation of cell migration | 1.95e-03 | 1.00e+00 | 4.914 | 2 | 2 | 36 |
GO:0006396 | RNA processing | 2.40e-03 | 1.00e+00 | 4.762 | 2 | 4 | 40 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 2 |
GO:0033688 | regulation of osteoblast proliferation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 2 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.03e-03 | 1.00e+00 | 4.383 | 2 | 8 | 52 |
GO:0006464 | cellular protein modification process | 5.51e-03 | 1.00e+00 | 4.153 | 2 | 4 | 61 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 3 |
GO:0071001 | U4/U6 snRNP | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 3 |
GO:0065002 | intracellular protein transmembrane transport | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 3 |
GO:2001275 | positive regulation of glucose import in response to insulin stimulus | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 3 |
GO:0005351 | sugar:proton symporter activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 3 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 4 |
GO:0071156 | regulation of cell cycle arrest | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 4 |
GO:0001649 | osteoblast differentiation | 8.01e-03 | 1.00e+00 | 3.874 | 2 | 5 | 74 |
GO:0005938 | cell cortex | 8.65e-03 | 1.00e+00 | 3.817 | 2 | 6 | 77 |
GO:0032287 | peripheral nervous system myelin maintenance | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0043931 | ossification involved in bone maturation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0031340 | positive regulation of vesicle fusion | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0006012 | galactose metabolic process | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 5 |
GO:0005829 | cytosol | 9.48e-03 | 1.00e+00 | 1.280 | 8 | 88 | 1787 |
GO:0030529 | ribonucleoprotein complex | 9.77e-03 | 1.00e+00 | 3.726 | 2 | 5 | 82 |
GO:0003723 | RNA binding | 9.85e-03 | 1.00e+00 | 2.720 | 3 | 22 | 247 |
GO:0050847 | progesterone receptor signaling pathway | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 6 |
GO:0043297 | apical junction assembly | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 4 | 7 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 7 |
GO:2000147 | positive regulation of cell motility | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 7 |
GO:0006301 | postreplication repair | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 4 | 7 |
GO:0010907 | positive regulation of glucose metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 7 |
GO:0005845 | mRNA cap binding complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 8 |
GO:0090314 | positive regulation of protein targeting to membrane | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 9 |
GO:0010225 | response to UV-C | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 9 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 4 | 10 |
GO:0008643 | carbohydrate transport | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 4 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 11 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 11 |
GO:0050772 | positive regulation of axonogenesis | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 14 |
GO:0005978 | glycogen biosynthetic process | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 15 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 4 | 15 |
GO:0032467 | positive regulation of cytokinesis | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 16 |
GO:0015992 | proton transport | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 1 | 16 |
GO:0005739 | mitochondrion | 2.94e-02 | 1.00e+00 | 1.719 | 4 | 32 | 659 |
GO:0005515 | protein binding | 3.20e-02 | 1.00e+00 | 0.659 | 12 | 198 | 4124 |
GO:0003899 | DNA-directed RNA polymerase activity | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 3 | 18 |
GO:0031047 | gene silencing by RNA | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 18 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 20 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 1 | 22 |
GO:0046326 | positive regulation of glucose import | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 1 | 22 |
GO:0016032 | viral process | 4.18e-02 | 1.00e+00 | 1.927 | 3 | 30 | 428 |
GO:0004842 | ubiquitin-protein transferase activity | 4.22e-02 | 1.00e+00 | 2.600 | 2 | 17 | 179 |
GO:0005634 | nucleus | 4.24e-02 | 1.00e+00 | 0.741 | 10 | 158 | 3246 |
GO:0072659 | protein localization to plasma membrane | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 1 | 24 |
GO:0008180 | COP9 signalosome | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 6 | 24 |
GO:0009267 | cellular response to starvation | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 1 | 26 |
GO:0051496 | positive regulation of stress fiber assembly | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.87e-02 | 1.00e+00 | 4.329 | 1 | 4 | 27 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 6 | 29 |
GO:0006446 | regulation of translational initiation | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 2 | 29 |
GO:0006281 | DNA repair | 5.29e-02 | 1.00e+00 | 2.418 | 2 | 24 | 203 |
GO:0016301 | kinase activity | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 30 |
GO:0032154 | cleavage furrow | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 3 | 30 |
GO:0045111 | intermediate filament cytoskeleton | 5.57e-02 | 1.00e+00 | 4.129 | 1 | 3 | 31 |
GO:0015030 | Cajal body | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 3 | 32 |
GO:0021762 | substantia nigra development | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 34 |
GO:0007266 | Rho protein signal transduction | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 2 | 35 |
GO:0031124 | mRNA 3'-end processing | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 4 | 35 |
GO:0044297 | cell body | 6.26e-02 | 1.00e+00 | 3.954 | 1 | 5 | 35 |
GO:0045444 | fat cell differentiation | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 1 | 36 |
GO:0003743 | translation initiation factor activity | 6.61e-02 | 1.00e+00 | 3.874 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.78e-02 | 1.00e+00 | 3.836 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 6.78e-02 | 1.00e+00 | 3.836 | 1 | 5 | 38 |
GO:0006417 | regulation of translation | 6.96e-02 | 1.00e+00 | 3.798 | 1 | 2 | 39 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 6 | 40 |
GO:0000775 | chromosome, centromeric region | 7.30e-02 | 1.00e+00 | 3.726 | 1 | 6 | 41 |
GO:0003684 | damaged DNA binding | 7.30e-02 | 1.00e+00 | 3.726 | 1 | 1 | 41 |
GO:0005524 | ATP binding | 7.53e-02 | 1.00e+00 | 1.283 | 4 | 37 | 892 |
GO:0006406 | mRNA export from nucleus | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 7 | 44 |
GO:0032869 | cellular response to insulin stimulus | 8.33e-02 | 1.00e+00 | 3.529 | 1 | 2 | 47 |
GO:0032481 | positive regulation of type I interferon production | 8.49e-02 | 1.00e+00 | 3.499 | 1 | 3 | 48 |
GO:0032587 | ruffle membrane | 8.83e-02 | 1.00e+00 | 3.440 | 1 | 3 | 50 |
GO:0006334 | nucleosome assembly | 9.00e-02 | 1.00e+00 | 3.411 | 1 | 4 | 51 |
GO:0006289 | nucleotide-excision repair | 9.34e-02 | 1.00e+00 | 3.356 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 9.34e-02 | 1.00e+00 | 3.356 | 1 | 3 | 53 |
GO:0005681 | spliceosomal complex | 9.68e-02 | 1.00e+00 | 3.302 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 1.00e-01 | 1.00e+00 | 3.251 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 1.07e-01 | 1.00e+00 | 3.153 | 1 | 5 | 61 |
GO:0030018 | Z disc | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 3 | 64 |
GO:0030308 | negative regulation of cell growth | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 5 | 70 |
GO:0030496 | midbody | 1.26e-01 | 1.00e+00 | 2.894 | 1 | 6 | 73 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.29e-01 | 1.00e+00 | 1.670 | 2 | 23 | 341 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.31e-01 | 1.00e+00 | 2.836 | 1 | 2 | 76 |
GO:0044267 | cellular protein metabolic process | 1.36e-01 | 1.00e+00 | 1.624 | 2 | 14 | 352 |
GO:0006006 | glucose metabolic process | 1.38e-01 | 1.00e+00 | 2.762 | 1 | 3 | 80 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.43e-01 | 1.00e+00 | 2.708 | 1 | 2 | 83 |
GO:0001934 | positive regulation of protein phosphorylation | 1.43e-01 | 1.00e+00 | 2.708 | 1 | 1 | 83 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.44e-01 | 1.00e+00 | 2.691 | 1 | 5 | 84 |
GO:0030027 | lamellipodium | 1.50e-01 | 1.00e+00 | 2.624 | 1 | 3 | 88 |
GO:0061024 | membrane organization | 1.52e-01 | 1.00e+00 | 2.608 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 1.54e-01 | 1.00e+00 | 2.592 | 1 | 4 | 90 |
GO:0000209 | protein polyubiquitination | 1.57e-01 | 1.00e+00 | 2.560 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.57e-01 | 1.00e+00 | 2.560 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.60e-01 | 1.00e+00 | 2.529 | 1 | 9 | 94 |
GO:0008286 | insulin receptor signaling pathway | 1.65e-01 | 1.00e+00 | 2.484 | 1 | 2 | 97 |
GO:0006457 | protein folding | 1.65e-01 | 1.00e+00 | 2.484 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.68e-01 | 1.00e+00 | 2.454 | 1 | 6 | 99 |
GO:0044822 | poly(A) RNA binding | 1.78e-01 | 1.00e+00 | 1.026 | 3 | 45 | 799 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.80e-01 | 1.00e+00 | 2.342 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.88e-01 | 1.00e+00 | 2.276 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.92e-01 | 1.00e+00 | 2.238 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.98e-01 | 1.00e+00 | 2.189 | 1 | 7 | 119 |
GO:0016607 | nuclear speck | 2.03e-01 | 1.00e+00 | 2.153 | 1 | 8 | 122 |
GO:0006184 | GTP catabolic process | 2.15e-01 | 1.00e+00 | 2.061 | 1 | 7 | 130 |
GO:0030168 | platelet activation | 2.31e-01 | 1.00e+00 | 1.944 | 1 | 5 | 141 |
GO:0044212 | transcription regulatory region DNA binding | 2.33e-01 | 1.00e+00 | 1.924 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 2.49e-01 | 1.00e+00 | 1.817 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.59e-01 | 1.00e+00 | 1.753 | 1 | 18 | 161 |
GO:0005874 | microtubule | 2.62e-01 | 1.00e+00 | 1.735 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 2.71e-01 | 1.00e+00 | 1.674 | 1 | 10 | 170 |
GO:0007264 | small GTPase mediated signal transduction | 2.77e-01 | 1.00e+00 | 1.641 | 1 | 8 | 174 |
GO:0006412 | translation | 2.82e-01 | 1.00e+00 | 1.608 | 1 | 12 | 178 |
GO:0016567 | protein ubiquitination | 2.95e-01 | 1.00e+00 | 1.529 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 2.95e-01 | 1.00e+00 | 1.529 | 1 | 10 | 188 |
GO:0005856 | cytoskeleton | 2.98e-01 | 1.00e+00 | 1.514 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 8 | 197 |
GO:0005525 | GTP binding | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 3.10e-01 | 1.00e+00 | 1.447 | 1 | 8 | 199 |
GO:0007165 | signal transduction | 3.17e-01 | 1.00e+00 | 0.812 | 2 | 24 | 618 |
GO:0019899 | enzyme binding | 3.24e-01 | 1.00e+00 | 1.369 | 1 | 7 | 210 |
GO:0030054 | cell junction | 3.34e-01 | 1.00e+00 | 1.315 | 1 | 5 | 218 |
GO:0005737 | cytoplasm | 3.52e-01 | 1.00e+00 | 0.306 | 6 | 127 | 2633 |
GO:0007411 | axon guidance | 3.58e-01 | 1.00e+00 | 1.195 | 1 | 8 | 237 |
GO:0006508 | proteolysis | 3.90e-01 | 1.00e+00 | 1.039 | 1 | 11 | 264 |
GO:0005730 | nucleolus | 3.93e-01 | 1.00e+00 | 0.419 | 3 | 74 | 1217 |
GO:0000139 | Golgi membrane | 3.93e-01 | 1.00e+00 | 1.023 | 1 | 2 | 267 |
GO:0008285 | negative regulation of cell proliferation | 4.05e-01 | 1.00e+00 | 0.970 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 4.10e-01 | 1.00e+00 | 0.944 | 1 | 14 | 282 |
GO:0009986 | cell surface | 4.20e-01 | 1.00e+00 | 0.899 | 1 | 5 | 291 |
GO:0006468 | protein phosphorylation | 4.31e-01 | 1.00e+00 | 0.850 | 1 | 6 | 301 |
GO:0000278 | mitotic cell cycle | 4.45e-01 | 1.00e+00 | 0.789 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.48e-01 | 1.00e+00 | 0.775 | 1 | 17 | 317 |
GO:0055085 | transmembrane transport | 4.61e-01 | 1.00e+00 | 0.722 | 1 | 13 | 329 |
GO:0007596 | blood coagulation | 4.71e-01 | 1.00e+00 | 0.678 | 1 | 13 | 339 |
GO:0042802 | identical protein binding | 4.86e-01 | 1.00e+00 | 0.616 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.08e-01 | 1.00e+00 | 0.525 | 1 | 21 | 377 |
GO:0046872 | metal ion binding | 5.25e-01 | 1.00e+00 | 0.216 | 2 | 24 | 934 |
GO:0003677 | DNA binding | 5.33e-01 | 1.00e+00 | 0.196 | 2 | 52 | 947 |
GO:0006915 | apoptotic process | 5.39e-01 | 1.00e+00 | 0.400 | 1 | 15 | 411 |
GO:0005794 | Golgi apparatus | 5.43e-01 | 1.00e+00 | 0.387 | 1 | 6 | 415 |
GO:0045087 | innate immune response | 5.74e-01 | 1.00e+00 | 0.263 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.78e-01 | 1.00e+00 | 0.251 | 1 | 29 | 456 |
GO:0070062 | extracellular vesicular exosome | 6.04e-01 | 1.00e+00 | -0.012 | 3 | 51 | 1641 |
GO:0005886 | plasma membrane | 6.65e-01 | 1.00e+00 | -0.132 | 3 | 46 | 1784 |
GO:0005887 | integral component of plasma membrane | 6.65e-01 | 1.00e+00 | -0.084 | 1 | 8 | 575 |
GO:0016020 | membrane | 6.71e-01 | 1.00e+00 | -0.154 | 2 | 56 | 1207 |
GO:0006355 | regulation of transcription, DNA-templated | 7.46e-01 | 1.00e+00 | -0.398 | 1 | 31 | 715 |
GO:0016021 | integral component of membrane | 9.53e-01 | 1.00e+00 | -1.492 | 1 | 19 | 1526 |